215 related articles for article (PubMed ID: 22808693)
1. [Antimicrobial susceptibility of clinical isolates of aerobic gram-positive cocci and anaerobic bacteria in 2008].
Yoshida I; Yamaguchi T; Kudo R; Fuji R; Takahashi C; Oota R; Kaku M; Kunishima H; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Fujita S; Matsuo S; Kono H; Asari S; Toyokawa M; Kusano N; Nose M; Horii T; Tanimoto A; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
Jpn J Antibiot; 2012 Feb; 65(1):49-72. PubMed ID: 22808693
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2006].
Yamaguchi T; Yoshida I; Itoh Y; Tachibana M; Takahashi C; Kaku M; Kanemitsu K; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Baba H; Matsuo S; Asari S; Toyokawa M; Matsuoka K; Kusano N; Nose M; Murase M; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
Jpn J Antibiot; 2010 Dec; 63(6):431-56. PubMed ID: 21425596
[TBL] [Abstract][Full Text] [Related]
3. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Nakashio S; Iwasawa H; Iino S; Shimada J
Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
[TBL] [Abstract][Full Text] [Related]
4. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
[TBL] [Abstract][Full Text] [Related]
5. [An antimicrobial resistance surveillance of gram-positive cocci isolated from 12 teaching hospitals in China in 2009].
Sun HL; Wang H; Chen MJ; Liu YM; Hu ZD; Liao K; Chu YZ; Lei JE; Zhang B; Yu YS; Hu BJ; Sun ZY; Zhang Z; He QY
Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):735-40. PubMed ID: 21092441
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.
Sader HS; Jones RN; Ballow CH; Biedenbach DJ; Cered RF;
Braz J Infect Dis; 2001 Feb; 5(1):21-31. PubMed ID: 11290311
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of daptomycin and other antimicrobial agents against 499 strains of gram-positive cocci causing bloodstream infection].
Yang QW; Wang H; Sun HL; Xu YC; Xie XL; Chen MJ
Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):220-4. PubMed ID: 19576091
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species.
Marchese A; Salerno A; Pesce A; Debbia EA; Schito GC
Chemotherapy; 2000; 46(4):253-66. PubMed ID: 10859431
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
Ueda Y; Sunagawa M
Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
[TBL] [Abstract][Full Text] [Related]
10. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.
Goldstein EJ; Citron DM; Merriam CV; Tyrrell KL
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):347-51. PubMed ID: 23623385
[TBL] [Abstract][Full Text] [Related]
13. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
14. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700
[TBL] [Abstract][Full Text] [Related]
16. [A study of in vitro activity of daptomycin against 2679 Gram-positive cocci].
Zhang FF; Zhao CJ; Wang ZW; Liu WY; Yan W; Peng QS; Jiang S; Guo Y; Liu JB; Chen HB; Li HN; Wang Q; Wang H
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):474-9. PubMed ID: 24059993
[TBL] [Abstract][Full Text] [Related]
17. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Feb; 55(1):1-21. PubMed ID: 11977919
[TBL] [Abstract][Full Text] [Related]
18. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents. Special references to bacteria isolated between April 1997 and March 1998].
Mashita K; Shinagawa N; Sato T; Hirata K; Katsuramaki T; Mukaiya M; Yura J; Ishibiki K; Ushijima Y; Manabe T; Takeyama H; Hasegawa M; Aikawa N; Yamazaki M; Ishikawa S; Iwai S; Kato K; Mizuno A; Kinoshita H; Morimoto K; Konaga E; Takeuchi H; Fujimoto M; Matsuura Y; Takesue Y; Tanimura H; Ohnishi H; Maeda T; Yokoyama T; Hiyama E; Tanaka N; Inoue F; Iwagaki H; Ikeda S; Yasunami Y; Fuchimoto S; Matsumoto Y; Suzuki Y; Tanaka S; Kimura H
Jpn J Antibiot; 2000 Aug; 53(8):533-65. PubMed ID: 11070817
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.
Singh KV; Malathum K; Murray BE
Antimicrob Agents Chemother; 2001 Dec; 45(12):3640-3. PubMed ID: 11709359
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea.
Hwang SH; Kim MN; Pai CH; Huh DH; Shin WS
Yonsei Med J; 2000 Oct; 41(5):563-9. PubMed ID: 11079615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
